Table 1.
Summary of findings
| Outcomes | Anticipated absolute effects † (95% CI) | Relative effect (95% CI) | No. participants (studies) | Quality of the evidence (GRADE) | |
|---|---|---|---|---|---|
| Risk with control | Risk with ACT | ||||
| HbA1c | Mean HbA1c change ranged from 7.81 to 8.07 | MD −0.62 lower (−1.07 lower to −0.16 lower) | – | 232 (3 RCTs) |
⨁⨁⊖⊖ LOW ‡ |
| SDSCA | Mean SDSCA change was 54.08 | MD 8.48 higher (2.16 higher to 14.8 higher) | – | 100 (1 RCTs) |
⨁⨁⨁⨁ HIGH |
| Adverse events | – | – | – | – | – |
| AADQ | Mean AADQ change ranged from 48.43 to 76.42 | MD 5.98 higher (1.42 higher to 10.54 higher) | – | 231 (3 RCTs) |
⨁⨁⊖⊖ |
AADQ, acceptance and action diabetes questionnaire; CI, confidence interval; HbA1c, glycated hemoglobin; MD, mean difference; SDSCA, summary of diabetes self‐care activities.
†
The risk in the intervention group (and its 95% confidence interval) was based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
‡
Participants were not blinded.
§
The intervention methods were complex.